Scientist to Watch

» evolution, genetics & genomics, microbiology and cancer

Most Recent

An entrepreneurial attitude helped this Vienna-based researcher begin to unravel the complex receptor network that Arabidopsis uses to  develop and defend itself.

0 Comments

The UCLA geneticist examines how defects in a histone protein lead to symptoms throughout the body.

0 Comments

The Purdue University researcher is one of the first to examine the molecular processes that underlie infection by soil microbes.

0 Comments

The Lawrence Berkeley National Laboratory researcher’s work will help predict how the Arctic is responding to climate change—and the global effects of those changes.

0 Comments

At Harvard University the chemical biologist looks for new metabolic pathways to investigate how gut bacteria interact with one another and their hosts.

1 Comment

image: Valerie Horsley Gets Under Skin

Valerie Horsley Gets Under Skin

By Kerry Grens | May 1, 2017

The Yale University cell and molecular biologist is probing the deep mysteries of epidermal cells.

1 Comment

image: Angela Brooks: Splicing Specialist

Angela Brooks: Splicing Specialist

By Diana Kwon | April 1, 2017

At the University of California, Santa Cruz, the researcher combs the cancer genome, looking for weaknesses.

0 Comments

image: Vlad Denic on Exploring New Fields and Failing Successfully

Vlad Denic on Exploring New Fields and Failing Successfully

By Ben Andrew Henry | December 1, 2016

The Harvard professor is pursuing fundamental questions about autophagy, protein homeostasis, and other cellular processes, and he’s always on the lookout for his next new topic.

2 Comments

image: Cullen Buie Parses Pathogens With Passion

Cullen Buie Parses Pathogens With Passion

By Andy Extance | August 1, 2016

Associate Professor, Department of Mechanical Engineering, MIT. Age: 34

1 Comment

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. North American Universities Increasingly Cancel Publisher Packages
  4. CRISPR Efficiency Tied to Cancer-Causing Process